• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

PAT-1251

CAS No. 2007885-39-2

PAT-1251 ( PAT 1251;PAT1251 )

产品货号. M13132 CAS No. 2007885-39-2

PAT-1251 (PAT 1251, PAT1251) is apotent, selective and orally bioavailable lysyl oxidase-like 2 (LOXL2) inhibitor with IC50 of 0.71 uM in human whole blood assays.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥4026 有现货
10MG ¥5856 有现货
25MG ¥9153 有现货
50MG ¥12312 有现货
100MG ¥16038 有现货
500MG ¥32157 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    PAT-1251
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    PAT-1251 (PAT 1251, PAT1251) is apotent, selective and orally bioavailable lysyl oxidase-like 2 (LOXL2) inhibitor with IC50 of 0.71 uM in human whole blood assays.
  • 产品描述
    PAT-1251 (PAT 1251, PAT1251) is apotent, selective and orally bioavailable lysyl oxidase-like 2 (LOXL2) inhibitor with IC50 of 0.71 uM in human whole blood assays, with high selectivity over LOX (400-fold) and other amine oxidases; exhibits efficacy in mouse bleomycin lung fibrosis model.Fibrosis Phase 1 Clinical
  • 同义词
    PAT 1251;PAT1251
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    Other Targets
  • 研究领域
    Other Indications
  • 适应症
    Fibrosis

化学信息

  • CAS Number
    2007885-39-2
  • 分子量
    399.35
  • 分子式
    C18H17F4N3O3
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO : ≥ 130 mg/mL 325.54 mM
  • SMILES
    O=C(C1=CC=CC(OC2=NC(C(F)(F)F)=CC(CN)=C2)=C1)N3C[C@@H](F)[C@H](O)C3
  • 化学全称
    (3-((4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl)oxy)phenyl)((3R,4R)-3-fluoro-4-hydroxypyrrolidin-1-yl)methanone

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Rowbottom MW, et al. J Med Chem. 2017 May 25;60(10):4403-4423.
产品手册
关联产品
  • Methyl nomilinate

    Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.

  • Ganoderlactone D

    Ganoderlactone D is a natural product.

  • 5,6,7-Trimethoxycoum...

    5,6,7-Trimethoxycoumarin shows moderate inhibitory activity against Micrococcus luteus, it also displays an intermediate cytotoxic effects against brine shrimp larvae. 5,6,7-Trimethoxycoumarin can improve gastroprotective effects, and it has low toxicity and minimal effects on drug-metabolizing enzymes.